Home
|
Contact Us
|
Bookmark
HBV
HE
HCC
HCV
About CLDF
Centers of Educational Expertise
CME Dinner Meetings
Webcasts
Slide Library
Abstract Library
Conference Highlights
Regulatory
Available Topics
06-10-2013
FDA wants more safety data on hepatitis B vaccine
03-18-2013
EU expands use of Pegasys to kids with chronic hepatitis C
02-25-2013
FDA rejects Dynavax's adult Hepatitis B vaccine on safety concerns
02-18-2013
US FDA okays everolimus to prevent liver transplant rejection
01-09-2013
FDA seeks more time to review drug for hepatitis C
11-19-2012
FDA expands use of eltrombopag to hepatitis C patients
11-16-2012
FDA panel backs Dynavax's hep B vaccine efficacy, not safety
04-26-2012
Don't mix boceprevir with certain HIV drugs: FDA
03-26-2012
FDA adds diabetes, memory loss warnings to statins
03-16-2012
UK cost body backs J&J's Incivo (telaprevir) for hepatitis C
03-08-2012
HCV drug Victrelis (boceprevir) wins UK cost endorsement
10-25-2011
US advisers recommend diabetics get Hep B vaccine
09-22-2011
EU regulator to review anti-obesity medicines
09-20-2011
Hepatitis C drug Incivo (telaprevir) gets EU nod
05-23-2011
Vertex hepatitis C drug Incivek (telaprevir) wins U.S. approval
05-13-2011
U.S. FDA clears new Merck protease inhibitor for hepatitis C
04-26-2011
US FDA panel backs efficacy of Vertex hepatitis drug
04-25-2011
US FDA sees safety issue with investigational Merck hepatitis drug
03-04-2011
FDA removes liver warning from Gilead drug
01-24-2011
EU agency reviews Sanofi's Multaq, backs Jevtana
01-13-2011
FDA seeks less acetaminophen in prescription drugs
05-26-2010
U.S. warns of liver risk with Glaxo, Roche diet drugs
05-12-2010
Promacta study in liver patients halted
03-24-2010
U.S. FDA OKs drug for hepatic encephalopathy
03-17-2010
WHO, UNICEF suspend use of Shantha Bio's vaccine: report
02-23-2010
US panel backs antibiotic for hepatic encephalopathy
04-28-2009
Pain drugs to carry stronger warnings: U.S. FDA
10-30-2008
Liver risk, death seen with Avandia: group
03-21-2008
EU follows U.S. with Tysabri liver warning
03-13-2008
J&J, FDA warn of liver risk with HIV drug Prezista
12-13-2007
Merck recalls 1.2 mln doses of children's vaccines
11-19-2007
Bayer's Nexavar gets U.S. FDA nod for liver cancer
10-04-2007
Canada pulls Prexige on hepatitis fears
09-21-2007
EU agency backs Bayer's Nexavar for liver cancer
08-13-2007
Australia bans Novartis's Prexige on liver worries
04-06-2007
US FDA clears Cangene's anti-hepatitis B product
03-07-2007
REFILE: Baraclude treatment of HBV may induce HIV resistance
03-01-2007
Baraclude treatment of HBV may induce HIV resistance
09-26-2006
WHO approves new child vaccine
06-28-2006
Commission approves Baraclude for chronic hepatitis B
04-28-2006
BMS' Baraclude and Sanofi Pasteur MSD's RotaTeq set for EU approval
02-22-2006
Britain's NICE backs Roche's Pegasys and Gilead's Hepsera for hepatitis B
02-07-2006
Canada: may be tie between Sanofi's Ketek, liver harm
01-10-2006
J&J recalls some hepatitis blood tests
10-05-2005
EU OKs briefer Schering-Plough hepatitis C therapy
08-15-2005
FDA approves use of Merck hepatitis A vaccine in 1-year-olds
05-16-2005
Roche gets FDA approval for Pegasys in hepatitis B
03-30-2005
Bayer gets FDA nod for hepatitis A blood test
03-30-2005
US FDA clears Bristol-Myers new drug for chronic hepatitis B
03-16-2005
US FDA, Biogen warn over multiple sclerosis drug
03-11-2005
Bristol-Myers hepatitis drug impressive - US panel
03-10-2005
Entecavir effective against hepatitis B
02-03-2005
Roche's Pegasys wins EU approval for HIV patients
02-03-2005
Lilly's Strattera may be associated with liver problems - UK agency
01-19-2005
US FDA warns about risks of Boehringer AIDS drug
01-18-2005
Bayer gets US FDA approval for hepatitis C test
10-06-2004
Roche hepatitis C drugs win fast review for use in HIV patients
07-13-2004
GlaxoSmithKline vaccine information wrong - US FDA
04-22-2004
CPMP lifts ban on Roche's Parkinson's drug Tasmar
10-21-2003
Europe drops liver biopsy for Schering-Plough's PegIntron
10-13-2003
FDA OKs Schering-Plough's Peg-Intron pen injector
08-29-2003
Bristol in talks with Canada over antidepressant
07-18-2003
EU approves label change for Pegasys/Copegus used to treat hepatitis C
HBV
Webcasts
Slide Library
Abstract Library
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
HCC
Slide Library
Abstract Library
HCV
Webcasts
Slide Library
Abstract Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of Educational Expertise
Regional Map
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation
terms of use
and
privacy statement
.